GlaxoSmithKline warns on European drug prices
Linkedin

GlaxoSmithKline warns on European drug prices

Mumbai : India | Oct 31, 2012 at 11:45 AM PDT
Source: The Guardian
XX XX
Views: Pending
 
Andrew Witty, CEO of GlaxoSmithKline, has warned on European drug prices. Photograph: Linda Nylind for the Guardian GlaxoSmithKline boss Sir Andrew Witty said on Wednesday that pharmaceutical companies could scale back on innovation and decamp to Asia or the US if European governments continued... FULL ARTICLE AT The Guardian
1 of 1
Benlysta is an experimental drug therapy developed by pharmaceutical companies Human Genome Sciences and GlaxoSmithKlin
Benlysta is an experimental drug therapy developed by pharmaceutical companies Human Genome Sciences and GlaxoSmithKlin
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

News Stories

 
  • GSK sales fall short as pain in Europe continues

      The Globe & Mail
    An exterior shot of Jean Coutu store in Longueuil, Quebec, May 2, 2012 Market View Pharmaceuticals A vile of Visudyne, a product produced by QLT, in Vancouver November 19, 2004. The Globe and Mail Acquisition It was the fourth consecutive quarter in...

Images

 >
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.